New data provides additional evidence for use of Fycompa in partial-onset epilepsy New data from 11 abstracts, including two oral presentations, presented at the 30th International Epilepsy Congress (IEC) in Montreal, Canada provide additional data on the safety, efficacy and impact on quality of life (QOL) of once daily Fycompa(R) (perampanel) as adjunct treatment in partial-onset epilepsy, the most common form of seizures...
More...
More...